OncoTartis Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $6M
Latest Deal Amount
  • Investors
  • 5

OncoTartis General Information

Description

Developer of anti-cancer drugs designed to help patients to recover from acute leukemia. The company's drugs develop biochemical and microbiological characteristics of materials and substances in terms of testing and analyzing the product, enabling patients to recover cancer and white cell diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 640 Ellicott Street
  • Suite 480
  • Buffalo, NY 14203
  • United States
+1 (716) 000-0000

OncoTartis Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoTartis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 11-Dec-2017 $6M 000.00 Completed Generating Revenue
4. Grant 07-Jun-2017 000.00 00.000 Completed Generating Revenue
3. Grant 00.000 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Jul-2016 $1.85M $8.25M Completed Generating Revenue
1. Early Stage VC (Series A) 17-Feb-2011 $6.4M $6.4M Completed Generating Revenue
To view OncoTartis’s complete valuation and funding history, request access »

OncoTartis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of anti-cancer drugs designed to help patients to recover from acute leukemia. The company's drugs develop bio
Drug Discovery
Buffalo, NY
3 As of 2020
000.00
0000000000 0 000.00

00000000

prehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000 000000000
Exton, PA
000 As of 0000
0000
0000 0000-00-00
000000&0 0000

00000000

rem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et
0000000000000
Gaithersburg, MD
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncoTartis Competitors (49)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Morphotek Formerly VC-backed Exton, PA 000 0000 000000&0 0000
000000000 Venture Capital-Backed Gaithersburg, MD 00 000.00 00000000000 000.00
00000 00000 000000 Venture Capital-Backed Geneva, Switzerland 000 00000 0000000000 0 00000
00000 000000000 Formerly VC-backed Boulder, CO 000 00000 000000&0 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
You’re viewing 5 of 49 competitors. Get the full list »

OncoTartis Executive Team (6)

Name Title Board Seat Contact Info
Andrei Gudkov Ph.D Co-Founder & Chief Scientific Officer
Aleksandra Kotlyarova Director, Operations
Olga Chernova Ph.D Co-Founder & Vice President, Research & Development
Alexander Polinsky Ph.D Co-Founder & Chief Executive Officer
Eric Rowinsky MD Chief Medical Officer
You’re viewing 5 of 6 executive team members. Get the full list »

OncoTartis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoTartis Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Norma Investments Venture Capital Minority 000 0000 000000 0
Pharmstandard Corporation Minority 000 0000 000000 0
Startup Village Other 000 0000 000000 0
Bioprocess Capital Partners Venture Capital Minority 000 0000 000000 0
Skolkovo Foundation Limited Partner 000 0000 000000 0
To view OncoTartis’s complete investors history, request access »